Draft-National Occupational Research Agenda for Healthcare and Social Assistance, 28849-28850 [2018-13308]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 120 / Thursday, June 21, 2018 / Notices
General Counsel Certification
The General Counsel has certified that
Matter Number Two may properly be
closed, citing the following relevant
exemptive provision: 5 U.S.C.
552b(c)(10).
Expected Attendees
Expected to attend the closed meeting
are the Commissioners themselves, an
advisor to one of the Commissioners,
and such other Commission staff as may
be appropriate.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2018–13327 Filed 6–20–18; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[Docket No. ATSDR–2015–0004]
Availability of Draft Toxicological
Profile: Perfluoroalkyls
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice of availability; request
for comments.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), within the Department of
Health and Human Services (HHS)
announces the availability of the Draft
Toxicological Profile for Perfluoroalkyls
for review and comment. All
toxicological profiles issued as ‘‘Drafts
for Public Comment’’ represent
ATSDR’s best efforts to provide
important toxicological information on
priority hazardous substances. ATSDR
is seeking public comments and
additional information, reports, and
studies about the health effects of these
substances. Although ATSDR considers
key studies for this substance during the
profile development process, this
document solicits any relevant,
additional studies. ATSDR will evaluate
the quality and relevance of such data
or studies for possible inclusion into the
profile. ATSDR remains committed to
providing a comment period for this
document as a means to best serve
public health.
DATES: Comments must be submitted by
July 23, 2018.
ADDRESSES: You may submit comments,
identified by docket number ATSDR–
amozie on DSK3GDR082PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:22 Jun 20, 2018
Jkt 244001
2015–0004, by any of the following
methods:
• Internet: Access the Federal
eRulemaking Portal at
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Division of Toxicology and
Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329. Attn: Docket No. ATSDR–
2015–0004.
Instructions: All submissions must
include the agency name and docket
number for this notice. All relevant
comments will be posted without
change. This means that no confidential
business information or other
confidential information should be
submitted in response to this notice.
FOR FURTHER INFORMATION CONTACT:
Susan Ingber, Division of Toxicology
and Human Health Sciences, Agency for
Toxic Substances and Disease Registry,
1600 Clifton Rd. NE, MS F–57, Atlanta,
GA 30329, Email: wng7@cdc.gov;
Phone: 770–488–0605.
SUPPLEMENTARY INFORMATION: The
Superfund Amendments and
Reauthorization Act of 1986 (SARA) [42
U.S.C. 9601 et seq.] amended the
Comprehensive Environmental
Response, Compensation, and Liability
Act of 1980 (CERCLA or Superfund) [42
U.S.C. 9601 et seq.] by establishing
certain requirements for ATSDR and the
U.S. Environmental Protection Agency
(EPA) regarding hazardous substances
that are most commonly found at
facilities on the CERCLA National
Priorities List (NPL). Among these
statutory requirements is a mandate for
the Administrator of ATSDR to prepare
toxicological profiles for each substance
included on the priority list of
hazardous substances [also called the
Substance Priority List (SPL)]. This list
identifies 275 hazardous substances that
ATSDR and EPA have determined pose
the most significant potential threat to
human health. The SPL is available
online at www.atsdr.cdc.gov/spl.
In addition, CERCLA provides ATSDR
with the authority to prepare
toxicological profiles for substances not
found on the SPL. CERCLA authorizes
ATSDR to establish and maintain
inventory of literature, research, and
studies on the health effects of toxic
substances (CERCLA section
104(i)(1)(B)); to respond to requests for
health consultations (CERCLA section
104(i)(4)); and to support the sitespecific response actions conducted by
the agency.
There have been two previous Public
Comment periods for the
Perfluoroalkyls toxicological profile,
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
28849
one in 2009 (74 FR 36492) and 2015 (80
FR 53157). Due to the public comments
received to both notices, as well as new
literature, we have revised the previous
draft profile (including a revised
Minimal Risk Level); therefore, ATSDR
is releasing a revised draft profile for
public comment.
Availability
The Draft Toxicological Profiles are
available online at https://www.atsdr.
cdc.gov/ToxProfiles and at
www.regulations.gov, Docket No.
ATSDR–2015–0004.
Pamela I. Protzel Berman,
Director, Office of Policy, Partnerships and
Planning Agency for Toxic Substances and
Disease Registry.
[FR Doc. 2018–13385 Filed 6–20–18; 8:45 am]
BILLING CODE 4163–70–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number CDC–2018–0050, NIOSH–
314]
Draft—National Occupational Research
Agenda for Healthcare and Social
Assistance
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Request for comment.
AGENCY:
The National Institute for
Occupational Safety and Health of the
Centers for Disease Control and
Prevention announces the availability of
a draft NORA Agenda entitled National
Occupational Research Agenda for
Healthcare and Social Assistance
(HCSA) for public comment. To view
the notice and related materials, visit
https://www.regulations.gov and enter
CDC–2018–0050 in the search field and
click ‘‘Search.’’
SUMMARY:
Table of Contents
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
Electronic or written comments
must be received by August 20, 2018.
ADDRESSES: You may submit comments,
identified by CDC–2018–0050 and
docket number NIOSH–314, by any of
the following methods:
DATES:
E:\FR\FM\21JNN1.SGM
21JNN1
amozie on DSK3GDR082PROD with NOTICES1
28850
Federal Register / Vol. 83, No. 120 / Thursday, June 21, 2018 / Notices
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: National Institute for
Occupational Safety and Health, NIOSH
Docket Office, 1090 Tusculum Avenue,
MS C–34, Cincinnati, Ohio 45226–1998.
Instructions: All submissions received
in response to this notice must include
the agency name and docket number
[CDC–2018–0050; NIOSH–314]. All
relevant comments received will be
posted without change to https://
www.regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. All
information received in response to this
notice will also be available for public
examination and copying at the NIOSH
Docket Office, 1150 Tusculum Avenue,
Room 155, Cincinnati, OH 45226–1998.
FOR FURTHER INFORMATION CONTACT:
Emily Novicki NORACoordinator@
cdc.gov), National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
Mailstop E–20, 1600 Clifton Road NE,
Atlanta, GA 30329, phone (404) 498–
2581 (not a toll free number).
SUPPLEMENTARY INFORMATION: The
National Occupational Research Agenda
(NORA) is a partnership program
created to stimulate innovative research
and improved workplace practices. The
national agenda is developed and
implemented through the NORA sector
and cross-sector councils. Each council
develops and maintains an agenda for
its sector or cross-sector.
Background: The National
Occupational Research Agenda for
Healthcare and Social Assistance
(HCSA) is intended to identify the
research, information, and actions most
urgently needed to prevent occupational
injuries. The National Occupational
Research Agenda for HCSA provides a
vehicle for stakeholders to describe the
most relevant issues, gaps, and safety
and health needs for the sector. Each
NORA research agenda is meant to
guide or promote high priority research
efforts on a national level, conducted by
various entities, including: government,
higher education, and the private sector.
The first National Occupational
Research Agenda for HCSA was
published in 2009 for the second decade
of NORA (2006–2016). The revised
agenda was developed considering new
information about injuries and illnesses,
the state of the science, and the
probability that new information and
approaches will make a difference. As
the steward of the NORA process,
NIOSH invites comments on the draft
VerDate Sep<11>2014
17:22 Jun 20, 2018
Jkt 244001
National Occupational Research
Agenda for HCSA. Comments
expressing support or with specific
recommendations to improve the
Agenda are requested. A copy of the
draft Agenda is available at https://
www.regulations.gov (see Docket
Number CDC–2018–0050).
John J. Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2018–13308 Filed 6–20–18; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–1073]
Antimicrobial Drugs Advisory
Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Antimicrobial Drugs
Advisory Committee. The general
function of the committee is to provide
advice and recommendations to FDA on
regulatory issues. The meeting will be
open to the public. FDA is establishing
a docket for public comment on this
document.
DATES: The meeting will be held on
August 8, 2018, from 8:30 a.m. to 1 p.m.
ADDRESSES: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (Rm.
1503), Silver Spring, MD 20993–0002.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/AboutAdvisory
Committees/ucm408555.htm.
FDA is establishing a docket for
public comment on this meeting. The
docket number is FDA–2018–N–1073.
The docket will close on August 7,
2018. Submit either electronic or
written comments on this public
meeting by August 7, 2018. Please note
that late, untimely filed comments will
not be considered. Electronic comments
must be submitted on or before August
7, 2018. The https://
www.regulations.gov electronic filing
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
system will accept comments until
midnight Eastern Time at the end of
August 7, 2018. Comments received by
mail/hand delivery/courier (for written/
paper submissions) will be considered
timely if they are postmarked or the
delivery service acceptance receipt is on
or before that date.
Comments received on or before July
24, 2018, will be provided to the
committee. Comments received after
that date will be taken into
consideration by FDA.
You may submit comments as
follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2018–N–1073 for ‘‘Antimicrobial Drugs
Advisory Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments.’’ Received
E:\FR\FM\21JNN1.SGM
21JNN1
]]>Agencies
[Federal Register Volume 83, Number 120 (Thursday, June 21, 2018)]
[Notices]
[Pages 28849-28850]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-13308]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number CDC-2018-0050, NIOSH-314]
Draft--National Occupational Research Agenda for Healthcare and
Social Assistance
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Request for comment.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health of
the Centers for Disease Control and Prevention announces the
availability of a draft NORA Agenda entitled National Occupational
Research Agenda for Healthcare and Social Assistance (HCSA) for public
comment. To view the notice and related materials, visit https://www.regulations.gov and enter CDC-2018-0050 in the search field and
click ``Search.''
Table of Contents
Dates
Addresses
For Further Information Contact
Supplementary Information
Background
DATES: Electronic or written comments must be received by August 20,
2018.
ADDRESSES: You may submit comments, identified by CDC-2018-0050 and
docket number NIOSH-314, by any of the following methods:
[[Page 28850]]
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: National Institute for Occupational Safety and
Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati,
Ohio 45226-1998.
Instructions: All submissions received in response to this notice
must include the agency name and docket number [CDC-2018-0050; NIOSH-
314]. All relevant comments received will be posted without change to
https://www.regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to https://www.regulations.gov. All information
received in response to this notice will also be available for public
examination and copying at the NIOSH Docket Office, 1150 Tusculum
Avenue, Room 155, Cincinnati, OH 45226-1998.
FOR FURTHER INFORMATION CONTACT: Emily Novicki
[email protected]), National Institute for Occupational Safety
and Health, Centers for Disease Control and Prevention, Mailstop E-20,
1600 Clifton Road NE, Atlanta, GA 30329, phone (404) 498-2581 (not a
toll free number).
SUPPLEMENTARY INFORMATION: The National Occupational Research Agenda
(NORA) is a partnership program created to stimulate innovative
research and improved workplace practices. The national agenda is
developed and implemented through the NORA sector and cross-sector
councils. Each council develops and maintains an agenda for its sector
or cross-sector.
Background: The National Occupational Research Agenda for
Healthcare and Social Assistance (HCSA) is intended to identify the
research, information, and actions most urgently needed to prevent
occupational injuries. The National Occupational Research Agenda for
HCSA provides a vehicle for stakeholders to describe the most relevant
issues, gaps, and safety and health needs for the sector. Each NORA
research agenda is meant to guide or promote high priority research
efforts on a national level, conducted by various entities, including:
government, higher education, and the private sector.
The first National Occupational Research Agenda for HCSA was
published in 2009 for the second decade of NORA (2006-2016). The
revised agenda was developed considering new information about injuries
and illnesses, the state of the science, and the probability that new
information and approaches will make a difference. As the steward of
the NORA process, NIOSH invites comments on the draft National
Occupational Research Agenda for HCSA. Comments expressing support or
with specific recommendations to improve the Agenda are requested. A
copy of the draft Agenda is available at https://www.regulations.gov
(see Docket Number CDC-2018-0050).
John J. Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2018-13308 Filed 6-20-18; 8:45 am]
BILLING CODE 4163-19-P
